Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 35380588000
Scopus Author ID: 57218539429
Researcher Name Resolver ID: 1000050636181
SciProfiles: 620364

Activities

Collapse all

Works (50 of 240)

Items per page:
Page 1 of 5

Efficacy and Safety of Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma in Patients 75 Years and Older: Multicenter Retrospective Study

Cancers
2025-01 | Journal article | Author
DOI: 10.3390/cancers17030474
Contributors: Shimpei Yamashita; Shuzo Hamamoto; Junya Furukawa; Kazutoshi Fujita; Masayuki Takahashi; Makito Miyake; Noriyuki Ito; Hideto Iwamoto; Yasuo Kohjimoto; Isao Hara
Source: check_circle
Multidisciplinary Digital Publishing Institute

The Natural HASPIN Inhibitor Coumestrol Suppresses Intestinal Polyp Development, Cachexia, and Hypogonadism in a Mouse Model of Familial Adenomatous Polyposis (<i>Apc<sup>Min/+</sup></i>)

Biology
2024-09 | Journal article | Author
DOI: 10.3390/biology13090736
Contributors: Hiromitsu Tanaka; Shunsuke Matsuyama; Tomoe Ohta; keisuke kakazu; Kazutoshi Fujita; Shinichiro Fukuhara; Tetsuji Soda; Yasushi Miyagawa; Akira Tsujimura
Source: check_circle
Multidisciplinary Digital Publishing Institute

Prognostic Factors of Platinum-Refractory Advanced Urothelial Carcinoma Treated with Pembrolizumab

Cancers
2023-12 | Journal article | Author
DOI: 10.3390/cancers15245780
Contributors: Yasunori Akashi; Yutaka Yamamoto; Mamoru Hashimoto; Shogo Adomi; Kazutoshi Fujita; Keisuke Kiba; Takafumi Minami; Kazuhiro Yoshimura; Akihide Hirayama; Hirotsugu Uemura
Source: check_circle
Multidisciplinary Digital Publishing Institute

Deep-learning-based differential diagnosis of follicular thyroid tumors using histopathological images.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2023-07-31 | Journal article
DOI: 10.1016/j.modpat.2023.100296
PMID: 37532181
Contributors: Nojima S; Kadoi T; Suzuki A; Kato C; Ishida S; Kido K; Fujita K; Okuno Y; Hirokawa M; Terayama K et al.
Source: Self-asserted source
Kazutoshi Fujita

Prognosis of Patients Receiving Chemotherapy for Metastatic Upper Tract Urothelial Carcinoma Compared With Metastatic Urinary Bladder Cancer.

Cancer diagnosis & prognosis
2023-07-03 | Journal article
DOI: 10.21873/cdp.10244
PMID: 37405216
PMC: PMC10316053
Contributors: Adomi S; Fujita K; Kita H; Kuwahara K; Akashi Y; Nishimoto M; Matsumura N; Sugimoto K; Minami T; Nozawa M et al.
Source: Self-asserted source
Kazutoshi Fujita

Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study.

Acta oncologica (Stockholm, Sweden)
2023-05-18 | Journal article
DOI: 10.1080/0284186x.2023.2213443
PMID: 37203203
Contributors: 0000-0001-8349-7873; Suzuki O; Otani K; Miyake A; Keisuke Tamari; Seo Y; Isohashi F; Kai N; Hatano K; Fujita K et al.
Source: Self-asserted source
Kazutoshi Fujita

External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy.

World journal of urology
2023-04-06 | Journal article
DOI: 10.1007/s00345-023-04380-5
PMID: 37024557
Contributors: Takafumi Minami; Fujita K; Hashimoto M; Nishimoto M; Adomi S; Banno E; Nozawa M; Nose K; Yoshimura K; Inada M et al.
Source: Self-asserted source
Kazutoshi Fujita

Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis

Cancers
2023-02 | Journal article | Author
DOI: 10.3390/cancers15051409
Contributors: Nico C. Grossmann; Francesco Soria; Tristan Juvet; Aaron M. Potretzke; Hooman Djaladat; Alireza Ghoreifi; Eiji Kikuchi; Andrea Mari; Zine-Eddine Khene; Kazutoshi Fujita et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Emerging Relationship between the Gut Microbiome and Prostate Cancer.

The world journal of men's health
2023-02-22 | Journal article | Author
DOI: 10.5534/wjmh.220202
PMID: 36876743
Contributors: Makoto Matsushita; Kazutoshi Fujita; Koji Hatano; Marco Antonio De Velasco; Akira Tsujimura; Hirotsugu Uemura; NORIO NONOMURA
Source: Self-asserted source
Kazutoshi Fujita

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome.

Cancers
2023-02-21 | Journal article
DOI: 10.3390/cancers15051375
PMID: 36900168
PMC: PMC10000196
Contributors: Fujita K; Matsushita M; Marco Antonio De Velasco; Hatano K; Minami T; Nonomura N; Hirotsugu Uemura
Source: Self-asserted source
Kazutoshi Fujita

Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma.

Anticancer research
2023-01-01 | Journal article
DOI: 10.21873/anticanres.16146
PMID: 36585180
Contributors: Hashimoto M; Fujita K; Tomiyama E; Fujimoto S; Adomi S; Banno E; Minami T; Takao T; Nozawa M; Fushimi H et al.
Source: Self-asserted source
Kazutoshi Fujita

The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer.

International journal of clinical oncology
2022-12-29 | Journal article
DOI: 10.1007/s10147-022-02288-5
PMID: 36580184
Contributors: Oka T; Koji Hatano; Okuda Y; Yamamoto A; Uemura T; Yamamichi G; Tomiyama E; Ishizuya Y; Yamamoto Y; Kato T et al.
Source: Self-asserted source
Kazutoshi Fujita

Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients - A Multicenter, Retrospective, Observational Study.

The Journal of urology
2022-12-07 | Journal article
DOI: 10.1097/ju.0000000000003085
PMID: 36475808
Contributors: Kazutoshi Fujita; Maximilian Pallauf; D'Andrea D; König F; Laukthina E; Yanagisawa T; Rouprêt M; Daneshmand S; Djaladat H; Ghoreifi A et al.
Source: Self-asserted source
Kazutoshi Fujita

Localization and potential role of prostate microbiota.

Frontiers in cellular and infection microbiology
2022-12-07 | Journal article
DOI: 10.3389/fcimb.2022.1048319
PMID: 36569206
PMC: PMC9768196
Contributors: Okada K; Takezawa K; Tsujimura G; Imanaka T; Kuribayashi S; Ueda N; Hatano K; Fukuhara S; Kiuchi H; Fujita K et al.
Source: Self-asserted source
Kazutoshi Fujita

Comparison of molecular profiles of upper tract urothelial carcinoma <i>vs.</i> urinary bladder cancer in the era of targeted therapy: a narrative review.

Translational andrology and urology
2022-12-01 | Journal article
DOI: 10.21037/tau-22-457
PMID: 36632153
PMC: PMC9827402
Contributors: Tomiyama E; Fujita K; Hashimoto M; Adomi S; Kawashima A; Minami T; Yoshimura K; Uemura H; Nonomura N
Source: Self-asserted source
Kazutoshi Fujita

Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference.

Translational andrology and urology
2022-12-01 | Journal article
DOI: 10.21037/tau-22-396
PMID: 36632151
PMC: PMC9827400
Contributors: Fujita K; Suzuki H; Hinata N; Miura Y; Edamura K; Tabata KI; Arai G; Matsubara N; Yasumizu Y; Kosaka T et al.
Source: Self-asserted source
Kazutoshi Fujita

A case of mediastinal teratoma with malignant transformation into angiosarcoma and relapse with multiple bone metastases that was cured by a multidisciplinary treatment.

IJU case reports
2022-11-11 | Journal article
DOI: 10.1002/iju5.12551
PMID: 36874996
PMC: PMC9978083
Contributors: Tani M; Akira Nagahara; Takada S; Fujita K; Shinichiro Fukuhara; Uemura M; Kiuchi H; Imamura R; Nonomura N
Source: Self-asserted source
Kazutoshi Fujita

Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy.

International journal of urology : official journal of the Japanese Urological Association
2022-11-09 | Journal article
DOI: 10.1111/iju.15061
PMID: 36349904
Contributors: Kazutoshi Fujita; Satoshi Katayama; Pradere B; Nico C. Grossmann; Aaron M. Potretzke; Boorjian SA; Alireza Ghoreifi; Daneshmand S; Djaladat H; Sfakianos JP et al.
Source: Self-asserted source
Kazutoshi Fujita

Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients.

World journal of urology
2022-11-04 | Journal article
DOI: 10.1007/s00345-022-04200-2
PMID: 36331614
Contributors: Kazutoshi Fujita; Takashi Ueda; Fujita K; Nishimoto M; Shiraishi T; Miyashita M; Kayukawa N; Nakamura Y; Sako S; Ogura R et al.
Source: Self-asserted source
Kazutoshi Fujita

The Association of Tumor Immune Microenvironment of the Primary Lesion with Time to Metastasis in Patients with Renal Cell Carcinoma: A Retrospective Analysis.

Cancers
2022-10-26 | Journal article | Author
DOI: 10.3390/cancers14215258
PMID: 36358675
Contributors: Kazutoshi Fujita; GO KIMURA; Toyonori Tsuzuki; Kato T; Eri Banno; Kazama A; Yamashita R; Yuto Matsushita; Ishii D; Tomoya Fukawa et al.
Source: Self-asserted source
Kazutoshi Fujita

Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer.

Scientific reports
2022-10-05 | Journal article
DOI: 10.1038/s41598-022-21158-8
PMID: 36198773
PMC: PMC9535027
Contributors: Kazutoshi Fujita
Source: Self-asserted source
Kazutoshi Fujita

The pressure flow study investigation of pathophysiology of post-micturition dribble in male patients.

International urology and nephrology
2022-09-20 | Journal article
DOI: 10.1007/s11255-022-03367-2
PMID: 36125621
Contributors: Kazutoshi Fujita
Source: Self-asserted source
Kazutoshi Fujita

Sequential therapy with darolutamide in patients with non-metastatic castration-resistant prostate cancer resistant to enzalutamide or apalutamide.

Cancer medicine
2022-08-31 | Journal article
DOI: 10.1002/cam4.5189
PMID: 36043427
Contributors: Kazutoshi Fujita
Source: Self-asserted source
Kazutoshi Fujita

Current status and future perspectives of the managements of metastatic hormone-sensitive prostate cancer.

World journal of urology
2022-08-30 | Journal article
DOI: 10.1007/s00345-022-04134-9
PMID: 36040500
Contributors: Kazutoshi Fujita
Source: Self-asserted source
Kazutoshi Fujita

Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer.

Translational cancer research
2022-08-01 | Journal article
DOI: 10.21037/tcr-22-375
PMID: 36093511
PMC: PMC9459578
Contributors: Kazutoshi Fujita
Source: Self-asserted source
Kazutoshi Fujita

Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study.

International journal of clinical oncology
2022-07-13 | Journal article
DOI: 10.1007/s10147-022-02215-8
PMID: 35831538
Contributors: Kazutoshi Fujita
Source: Self-asserted source
Kazutoshi Fujita

EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer.

British journal of cancer
2022-07-06 | Journal article
DOI: 10.1038/s41416-022-01860-0
PMID: 35794239
Contributors: Kazutoshi Fujita
Source: Self-asserted source
Kazutoshi Fujita

Trop-2 in Upper Tract Urothelial Carcinoma

Current Oncology
2022-05 | Journal article | Author
DOI: 10.3390/curroncol29060312
Contributors: Eisuke Tomiyama; Kazutoshi Fujita; Kosuke Nakano; Ken Kuwahara; Takafumi Minami; Taigo Kato; Koji Hatano; Atsunari Kawashima; Motohide Uemura; Tetsuya Takao et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

High-fat diet promotes prostate cancer growth through histamine signaling.

International journal of cancer
2022-04-11 | Journal article
DOI: 10.1002/ijc.34028
PMID: 35403732
Source: Self-asserted source
Kazutoshi Fujita

Gut microbiome and prostate cancer.

International journal of urology : official journal of the Japanese Urological Association
2022-04-06 | Journal article
DOI: 10.1111/iju.14894
PMID: 35388531
Contributors: Kazutoshi Fujita
Source: Self-asserted source
Kazutoshi Fujita

Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics

Cancers
2022-03 | Journal article | Author
DOI: 10.3390/cancers14071781
Contributors: Frederik König; Nico C. Grossmann; Francesco Soria; David D'Andrea; Tristan Juvet; Aaron Potretzke; Hooman Djaladat; Alireza Ghoreifi; Eiji Kikuchi; Nozomi Hayakawa et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Perioperative Circulating Tumor DNA Enables Identification of Patients with Poor Prognosis in Upper Tract Urothelial Carcinoma.

Cancer science
2022-03-16 | Journal article
DOI: 10.1111/cas.15334
PMID: 35293110
Source: Self-asserted source
Kazutoshi Fujita

Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men.

The world journal of men's health
2022-02-24 | Journal article
DOI: 10.5534/wjmh.210190
PMID: 35274505
Source: Self-asserted source
Kazutoshi Fujita

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers.

International journal of clinical oncology
2022-02-04 | Journal article
DOI: 10.1007/s10147-021-02107-3
PMID: 35119579
Source: Self-asserted source
Kazutoshi Fujita

Decreased renal function increases the nighttime urine volume rate by carryover of salt excretion to the nighttime

Scientific Reports
2021-12 | Journal article
DOI: 10.1038/s41598-021-90166-x
Part of ISSN: 2045-2322
Source: Self-asserted source
Kazutoshi Fujita

Fucosylation in Urological Cancers

International Journal of Molecular Sciences
2021-12 | Journal article | Author
DOI: 10.3390/ijms222413333
Contributors: Kazutoshi Fujita; Koji Hatano; Mamoru Hashimoto; Eisuke Tomiyama; Eiji Miyoshi; Norio Nonomura; Hirotsugu Uemura
Source: check_circle
Multidisciplinary Digital Publishing Institute

Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis.

Frontiers in oncology
2021-12-21 | Journal article
DOI: 10.3389/fonc.2021.769068
PMID: 34993133
PMC: PMC8724311
Source: Self-asserted source
Kazutoshi Fujita

Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.

British journal of cancer
2021-11-20 | Journal article
DOI: 10.1038/s41416-021-01637-x
PMID: 34802050
Source: Self-asserted source
Kazutoshi Fujita

Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma.

International journal of urology : official journal of the Japanese Urological Association
2021-09-13 | Journal article
DOI: 10.1111/iju.14689
PMID: 34519113
Source: Self-asserted source
Kazutoshi Fujita

The Firmicutes/Bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement.

The Prostate
2021-09-13 | Journal article
DOI: 10.1002/pros.24223
PMID: 34516694
Source: Self-asserted source
Kazutoshi Fujita

Sarcopenia and Visceral Obesity are Significantly Related to Severe Storage Symptoms in Geriatric Female Patients

Research and Reports in Urology
2021-08 | Journal article
DOI: 10.2147/rru.s321323
Part of ISSN: 2253-2447
Source: Self-asserted source
Kazutoshi Fujita

Disseminated intravascular coagulation induced by pazopanib following combination therapy of nivolumab plus ipilimumab in a patient with metastatic renal cell carcinoma.

Anti-cancer drugs
2021-08-27 | Journal article
DOI: 10.1097/cad.0000000000001230
PMID: 34486537
Source: Self-asserted source
Kazutoshi Fujita

High Level of Phosphatidylcholines/Lysophosphatidylcholine Ratio in Urine is Associated with Prostate Cancer.

Cancer science
2021-07-30 | Journal article
DOI: 10.1111/cas.15093
PMID: 34328656
Source: Self-asserted source
Kazutoshi Fujita

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma

Frontiers in Oncology
2021-07-29 | Journal article
DOI: 10.3389/fonc.2021.705440
Part of ISSN: 2234-943X
Source: Self-asserted source
Kazutoshi Fujita

Efficacy of vibegron, a novel β3-adrenoreceptor agonist, for lower urinary tract dysfunction in mice with spinal cord injury.

International journal of urology : official journal of the Japanese Urological Association
2021-07-17 | Journal article
DOI: 10.1111/iju.14630
PMID: 34272910
Source: Self-asserted source
Kazutoshi Fujita

Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients.

Translational andrology and urology
2021-07-01 | Journal article
DOI: 10.21037/tau-21-185
PMID: 34430386
PMC: PMC8350230
Source: Self-asserted source
Kazutoshi Fujita

The gut microbiota associated with high-Gleason prostate cancer.

Cancer science
2021-05-29 | Journal article
DOI: 10.1111/cas.14998
PMID: 34051009
Source: Self-asserted source
Kazutoshi Fujita

Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF-1 signaling

Cancer Research
2021-05-26 | Journal article
DOI: 10.1158/0008-5472.can-20-4090
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Kazutoshi Fujita

A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens.

Cancer cytopathology
2021-05-12 | Journal article
DOI: 10.1002/cncy.22443
PMID: 33979039
Source: Self-asserted source
Kazutoshi Fujita

Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report.

Frontiers in oncology
2021-05-12 | Journal article
DOI: 10.3389/fonc.2021.691996
PMID: 34055654
PMC: PMC8149899
Source: Self-asserted source
Kazutoshi Fujita
grade
Preferred source (of 3)‎
Items per page:
Page 1 of 5

Peer review (26 reviews for 2 publications/grants)

Review activity for International journal of clinical oncology. (25)
Review activity for Prostate cancer and prostatic diseases (1)
How many people are using ORCID?